676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2)
Saved in:
| Title: | 676. Health-Related Quality of Life (HRQoL) as Measured by the 12-Item Medical Outcomes Study Short-Form (SF-12) Among Adults With Community-Acquired Bacterial Pneumonia (CABP) Who Received Either Lefamulin (LEF) or Moxifloxacin (MOX) in Two Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trials (LEAP 1 and 2) |
|---|---|
| Authors: | Lodise, Thomas1 (AUTHOR), Colman, Sam2 (AUTHOR), Alexander, Elizabeth3 (AUTHOR), Stein, Daniel3 (AUTHOR), Fitts, David3 (AUTHOR), Goldberg, Lisa3 (AUTHOR), Schranz, Jennifer3 (AUTHOR) |
| Source: | Open Forum Infectious Diseases. 2019 Supplement, Vol. 6, pS308-S309. 2p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 23288957 |
|---|---|
| DOI: | 10.1093/ofid/ofz360.744 |
